CD44 and hepatocellular carcinoma: CD133-positive and CD44-positive cells (unlike CD133-positive CD44-negative cells) exhibit stem-cell-like features in HCC cells and tumor xenograft models, such as widespread proliferation, self-renewal ability, high tumors, chemoresistance, and the expression of genes linked to stem cells [56].